Literature DB >> 24769316

Iron overload in allogeneic hematopoietic cell transplantation outcome: a meta-analysis.

Philippe Armand1, Haesook T Kim2, Johanna M Virtanen3, Riitta K Parkkola3, Maija A Itälä-Remes4, Navneet S Majhail5, Linda J Burns6, Todd DeFor7, Bryan Trottier6, Uwe Platzbecker8, Joseph H Antin9, Martin Wermke8.   

Abstract

An elevated ferritin level before allogeneic hematopoietic cell transplantation (HCT) is an adverse prognostic factor for overall survival (OS) and nonrelapse mortality. Because ferritin is an imperfect surrogate of iron stores, the prognostic role of iron overload remains unclear. We conducted a patient-level meta-analysis of 4 studies that used magnetic resonance imaging to estimate pre-HCT liver iron content (LIC). An elevated LIC was not associated with a significant increase in mortality: the hazard ratio (HR) for mortality associated with LIC > 7 mg/g dry weight (primary endpoint) was 1.4 (P = .18). In contrast, ferritin >1000 ng/mL was a significant prognostic factor (HR for mortality, 1.7; P = .036). There was, however, no significant association between ferritin > 2500 and mortality. This meta-analysis suggests that iron overload, as assessed by LIC, is not a strong prognostic factor for OS in a general adult HCT population. Our data also suggest that ferritin is an inadequate surrogate for iron overload in HCT.
Copyright © 2014 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Allogeneic hematopoietic cell transplantation; Iron overload; Serum ferritin

Mesh:

Substances:

Year:  2014        PMID: 24769316      PMCID: PMC4099413          DOI: 10.1016/j.bbmt.2014.04.024

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  30 in total

1.  Iron overload: predictor of adverse outcome in hematopoietic stem cell transplantation.

Authors:  G T Sucak; Z A Yegin; Z N Ozkurt; S Z Aki; M Yağci
Journal:  Transplant Proc       Date:  2010-06       Impact factor: 1.066

2.  Noninvasive measurement of liver iron concentration at MRI in children with acute leukemia: initial results.

Authors:  Tibor Vag; Karim Kentouche; Ines Krumbein; Jürgen R Reichenbach; Eric Lopatta; Diane M Renz; Martin Stenzel; James Beck; Werner A Kaiser; Hans-Joachim Mentzel
Journal:  Pediatr Radiol       Date:  2011-06-15

3.  Does iron overload really matter in stem cell transplantation?

Authors:  Philippe Armand; Marie-Michele Sainvil; Haesook T Kim; Joanna Rhodes; Corey Cutler; Vincent T Ho; John Koreth; Edwin P Alyea; Ellis J Neufeld; Raymond Y Kwong; Robert J Soiffer; Joseph H Antin
Journal:  Am J Hematol       Date:  2012-04-04       Impact factor: 10.047

4.  Efficacy and safety of oral deferasirox treatment in the posttransplant period for patients who have undergone allogeneic hematopoietic stem cell transplantation (alloHSCT).

Authors:  Serdar Sivgin; Bulent Eser; Sami Bahcebasi; Leylagul Kaynar; Fatih Kurnaz; Elmas Uzer; Cigdem Pala; Kemal Deniz; Ahmet Ozturk; Mustafa Cetin; Ali Unal
Journal:  Ann Hematol       Date:  2011-11-04       Impact factor: 3.673

5.  Pre-transplantation iron chelation in patients with MDS or acute leukemia and iron overload undergoing myeloablative allo-SCT.

Authors:  P Armand; M-M Sainvil; H T Kim; J Rhodes; C Cutler; V T Ho; J Koreth; E P Alyea; E J Neufeld; R Y Kwong; R J Soiffer; J H Antin
Journal:  Bone Marrow Transplant       Date:  2012-05-21       Impact factor: 5.483

6.  Iron overload and iron chelation therapy in patients with myelodysplastic syndrome treated by allogeneic stem-cell transplantation: report from the working conference on iron chelation of the Gruppo Italiano Trapianto di Midollo Osseo.

Authors:  Emilio Paolo Alessandrino; Emanuele Angelucci; Mario Cazzola; Matteo Giovanni Della Porta; Paolo Di Bartolomeo; Antonella Gozzini; Luca Malcovati; Pietro Pioltelli; Simona Sica; Alberto Bosi
Journal:  Am J Hematol       Date:  2011-08-02       Impact factor: 10.047

7.  MRI-based liver iron content predicts for nonrelapse mortality in MDS and AML patients undergoing allogeneic stem cell transplantation.

Authors:  Martin Wermke; Anne Schmidt; Jan Moritz Middeke; Katja Sockel; Malte von Bonin; Claudia Schönefeldt; Sabine Mair; Verena Plodeck; Michael Laniado; Günter Weiss; Johannes Schetelig; Gerhard Ehninger; Igor Theurl; Martin Bornhäuser; Uwe Platzbecker
Journal:  Clin Cancer Res       Date:  2012-09-18       Impact factor: 12.531

8.  Prognostic impact of iron parameters in patients undergoing allo-SCT.

Authors:  G N Bazuaye; G N Bazuave; A Buser; S Gerull; A Tichelli; M Stern
Journal:  Bone Marrow Transplant       Date:  2011-03-14       Impact factor: 5.483

9.  A prospective study of iron overload management in allogeneic hematopoietic cell transplantation survivors.

Authors:  Navneet S Majhail; Hillard M Lazarus; Linda J Burns
Journal:  Biol Blood Marrow Transplant       Date:  2010-01-14       Impact factor: 5.742

10.  Prognostic impact of posttransplantation iron overload after allogeneic stem cell transplantation.

Authors:  Sara C Meyer; Alix O'Meara; Andreas S Buser; André Tichelli; Jakob R Passweg; Martin Stern
Journal:  Biol Blood Marrow Transplant       Date:  2012-10-23       Impact factor: 5.742

View more
  23 in total

1.  A prospective cohort study of the feasibility and efficacy of iron reduction by phlebotomy in recipients of hematopoietic SCT.

Authors:  A K Kew; S Clarke; A Ridler; S Burrell; J-A Edwards; S Doucette; S Couban
Journal:  Bone Marrow Transplant       Date:  2014-12-15       Impact factor: 5.483

Review 2.  Patient selection for allogeneic hematopoietic cell transplantation (HCT): the evolution of HCT risk assessment.

Authors:  Lori Muffly
Journal:  Curr Hematol Malig Rep       Date:  2015-03       Impact factor: 3.952

3.  Association between pretransplant iron overload determined by bone marrow pathological analysis and bacterial infection.

Authors:  A Ohmoto; S Fuji; A Miyagi-Maeshima; S-W Kim; K Tajima; T Tanaka; K Okinaka; S Kurosawa; Y Inamoto; H Taniguchi; T Fukuda
Journal:  Bone Marrow Transplant       Date:  2017-05-15       Impact factor: 5.483

4.  Pre-transplant ferritin, albumin and haemoglobin are predictive of survival outcome independent of disease risk index following allogeneic stem cell transplantation.

Authors:  L Chee; M Tacey; B Lim; A Lim; J Szer; D Ritchie
Journal:  Bone Marrow Transplant       Date:  2017-05-15       Impact factor: 5.483

Review 5.  Modified diagnostic criteria, grading classification and newly elucidated pathophysiology of hepatic SOS/VOD after haematopoietic cell transplantation.

Authors:  Mitchell S Cairo; Kenneth R Cooke; Hillard M Lazarus; Nelson Chao
Journal:  Br J Haematol       Date:  2020-03-04       Impact factor: 6.998

Review 6.  Indication and management of allogeneic stem cell transplantation in primary myelofibrosis: a consensus process by an EBMT/ELN international working group.

Authors:  N M Kröger; J H Deeg; E Olavarria; D Niederwieser; A Bacigalupo; T Barbui; A Rambaldi; R Mesa; A Tefferi; M Griesshammer; V Gupta; C Harrison; H Alchalby; A M Vannucchi; F Cervantes; M Robin; M Ditschkowski; V Fauble; D McLornan; K Ballen; U R Popat; F Passamonti; D Rondelli; G Barosi
Journal:  Leukemia       Date:  2015-08-21       Impact factor: 11.528

Review 7.  Iron overload in myelodysplastic syndromes (MDS).

Authors:  Norbert Gattermann
Journal:  Int J Hematol       Date:  2017-11-25       Impact factor: 2.490

8.  Organ siderosis and hemophagocytosis during acute graft-versus-host disease.

Authors:  Axel Nogai; Yu Shi; Daniel Pérez-Hernandez; Steffen Cordes; Jörg Mengwasser; Sarah Mertlitz; Katarina Riesner; Martina Kalupa; Jan-Hendrik Erdmann; Reinhard Ziebig; Gunnar Dittmar; Olaf Penack
Journal:  Haematologica       Date:  2016-05-19       Impact factor: 9.941

9.  The prognostic value of serum C-reactive protein, ferritin, and albumin prior to allogeneic transplantation for acute myeloid leukemia and myelodysplastic syndromes.

Authors:  Andrew S Artz; Brent Logan; Xiaochun Zhu; Gorgun Akpek; Rodrigo Martino Bufarull; Vikas Gupta; Hillard M Lazarus; Mark Litzow; Alison Loren; Navneet S Majhail; Richard T Maziarz; Philip McCarthy; Uday Popat; Wael Saber; Stephen Spellman; Olle Ringden; Amittha Wickrema; Marcelo C Pasquini; Kenneth R Cooke
Journal:  Haematologica       Date:  2016-08-04       Impact factor: 9.941

10.  Refinement of the Glasgow Prognostic Score as a pre-transplant risk assessment for allogeneic hematopoietic cell transplantation.

Authors:  Yasuhiko Shibasaki; Tatsuya Suwabe; Takayuki Katagiri; Tomoyuki Tanaka; Takashi Ushiki; Kyoko Fuse; Naoko Sato; Toshio Yano; Takashi Kuroha; Shigeo Hashimoto; Miwako Narita; Tatsuo Furukawa; Hirohito Sone; Masayoshi Masuko
Journal:  Int J Hematol       Date:  2018-05-09       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.